Stryker Corp Settles Hip Claims For Over $1.4 Billion
Posted on behalf of Goldberg Finnegan, LLC on Nov 12, 2014 in Medical Malpractice
Stryker Corporation, the makers of Rejuvenate and ABG II brand artificial hip implants, agreed to pay more than a billion dollars to settle claims that its devices were defective.
The hip implants were recalled in 2012 after patients complained of pain, swelling, and metal debris detaching from the devices. The recall notices sent to physicians advised that the implants could wear away or corrode, leading to metal poisoning or failure of the implant.
The Stryker settlement comes after more than 4,000 separate lawsuits were consolidated in New Jersey and Minnesota courts. The company has set aside more than $1.4 billion dollars to settle these claims.
Patients who had the Stryker implants surgically removed and underwent revision surgery before November 3, 2014 will receive at least $300,000 in compensation. Patients may receive more money if multiple surgeries were required to fix the implants, or if they suffered additional medical complications. If the devices were implanted in both hips, then patients are eligible for double the settlement amount.
Approximately 20,000 people across the United States were implanted with the Rejuvenate or ABG II hip implants. Patients who need revision surgery after the November 3, 2014 cut-off date are not eligible for this settlement, but will still be able to pursue lawsuits against Stryker Corp. individually.
For more information about the settlement, go to www.strykermodularhipsettlement.com. Stryker Corp. estimates that the settlement funds will be released by the end of 2015.
If you or your loved one had a hip replacement which failed, needed to be replaced, or caused medical complications like blood poisoning, you may be eligible for compensation. The personal injury attorneys at Goldberg Finnegan are investigating claims against Stryker, Johnson & Johnson, and other manufacturers of defective hip implants, and would like to hear from you.